Physician profile
Ryan A Davis
NPI 1972036184
$5,920.12
in general payments reported to CMS, 2019-2025
8 companies · $2,474 in 2025
The $2,474 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.99 · 2020: $63.45 · 2022: $253 · 2023: $1,063 · 2024: $2,000 · 2025: $2,474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,065 · Travel and Lodging: $2,270 · Education: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,065.26 |
| Travel and Lodging | $2,270.19 |
| Education | $201.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,429.55 | 2022-2025 | Mako, Insignia, Pangea |
| Zimmer Biomet Holdings, INC. | $1,553.01 | 2023-2025 | Persona, Rosa, Mymobility Platform |
| Arthrex, INC. | $462.45 | 2025 | |
| Reel Surgical, INC. | $166.64 | 2024 | |
| Si-Bone, INC. | $134.00 | 2022 | |
| Mallinckrodt Enterprises LLC | $66.99 | 2019 | |
| Mallinckrodt Hospital Products INC. | $63.45 | 2020 | |
| Smith+Nephew, INC. | $44.03 | 2023 | Evos, Evos Mini |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.